BackBionomics Overview

Bionomics Receivables

Track Bionomics's receivables ($1.6M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Receivables
$1.61M
↑ 6427.90% YoYΔ $1.58M vs prior year quarter

Peer trimmed avg / median

Loading

Bionomics Receivables History

Loading

Bionomics vs. peers: Receivables Comparison

Loading

Bionomics Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Bionomics (BNOX) FAQ

Bionomics (BNOX) currently reports a receivables of $1.6M as of March 2026. That compares with $25K in the prior-year period — up 6427.9% year over year. Use the charts on this page to explore Bionomics's receivables history and peer comparisons.

Bionomics's receivables increased from $25K to $1.6M — a 6427.9% year-over-year increase (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Bionomics reported $1.6M in receivables as of March 2026. That compares with $25K in the prior-year period — up 6427.9% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $1.6M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Bionomics, and consider following BNOX for alerts when major investors trade the stock.

Bionomics is classified in the Healthcare sector. On receivables, it currently shows $1.6M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing BNOX with unrelated industries.